Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study

Serum alpha‐fetoprotein (AFP) is the most commonly used tumor biomarker for screening and diagnosis of primary hepatocellular carcinoma (HCC). However, the predictive effect for HCC risk is still unsatisfactory. The aim of this prospective study was to estimate whether the individual genetic correct...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Wang, Ke, Bai, Yansen, Chen, Shi, Huang, Jiao, Yuan, Jing, Chen, Weihong, Yao, Ping, Miao, Xiaoping, Wang, Youjie, Liang, Yuan, Zhang, Xiaomin, He, Meian, Yang, Handong, Guo, Huan, Wei, Sheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Cancer Prevention
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://ncbi.nlm.nih.gov/pubmed/29696820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1481
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi